HomeCompareNHKFF vs BTI

NHKFF vs BTI: Dividend Comparison 2026

NHKFF yields 557.10% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NHKFF wins by $174318500157098033152.00M in total portfolio value
10 years
NHKFF
NHKFF
● Live price
557.10%
Share price
$0.36
Annual div
$2.00
5Y div CAGR
95.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$174318500157098033152.00M
Annual income
$174,243,062,167,289,250,000,000,000.00
Full NHKFF calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — NHKFF vs BTI

📍 NHKFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNHKFFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NHKFF + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NHKFF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NHKFF
Annual income on $10K today (after 15% tax)
$47,353.76/yr
After 10yr DRIP, annual income (after tax)
$148,106,602,842,195,860,000,000,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, NHKFF beats the other by $148,106,602,842,195,860,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NHKFF + BTI for your $10,000?

NHKFF: 50%BTI: 50%
100% BTI50/50100% NHKFF
Portfolio after 10yr
$87159250078549016576.00M
Annual income
$87,121,531,083,644,620,000,000,000.00/yr
Blended yield
99.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

NHKFF
No analyst data
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NHKFF buys
0
BTI buys
0
No recent congressional trades found for NHKFF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNHKFFBTI
Forward yield557.10%5.38%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR95.5%11.3%
Portfolio after 10y$174318500157098033152.00M$37.7K
Annual income after 10y$174,243,062,167,289,250,000,000,000.00$2,786.64
Total dividends collected$174313561310925258752.00M$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: NHKFF vs BTI ($10,000, DRIP)

YearNHKFF PortfolioNHKFF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$119,614$108,913.65$11,299$598.92+$108.3KNHKFF
2$2,508,256$2,380,268.96$12,794$703.91+$2.50MNHKFF
3$93,880,730$91,196,896.77$14,518$829.07+$93.87MNHKFF
4$6,337,049,933$6,236,597,552.02$16,513$978.64+$6337.03MNHKFF
5$775,948,938,114$769,168,294,685.67$18,827$1,157.84+$775948.92MNHKFF
6$172,910,255,380,782$172,079,990,016,999.80$21,518$1,373.12+$172910255.36MNHKFF
7$70,246,761,459,188,210$70,061,747,485,930,776.00$24,657$1,632.46+$70246761459.16MNHKFF
8$52,080,691,335,612,070,000$52,005,527,300,850,740,000.00$28,329$1,945.74+$52080691335612.05MNHKFF
9$70,502,794,213,834,740,000,000$70,447,067,874,105,630,000,000.00$32,637$2,325.33+$70502794213834736.00MNHKFF
10$174,318,500,157,098,050,000,000,000$174,243,062,167,289,250,000,000,000.00$37,708$2,786.64+$174318500157098033152.00MNHKFF

NHKFF vs BTI: Complete Analysis 2026

NHKFFStock

Nichi-Iko Pharmaceutical Co., Ltd. manufactures, sells, and distributes various pharmaceutical products. It operates through two segments, Nichi-Iko Group and Sagent Group. The company primarily focuses on the production of generic drugs. It offers antidiabetic agents, antacids, antireflux agents, beta-blocker, hypnotic and sedative, angiotensin ? antagonist, angiotensin ? antagonist/diuretic combination, dyslipidaemic agent, and calcium antagonist products, as well as chemotherapeutic agents. The company also provides treatments for circulatory, digestive, respiratory, nervous system, allergies, and others. It supplies its products to medical institutions, including hospitals, clinics, dispensing pharmacies, etc. The company was formerly known as Nihon Iyakuhin Kogyo Co., Ltd. and changed its name to Nichi-Iko Pharmaceutical Co., Ltd. in 2005. Nichi-Iko Pharmaceutical Co., Ltd. was incorporated in 1947 and is headquartered in Toyama, Japan.

Full NHKFF Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this NHKFF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NHKFF vs SCHDNHKFF vs JEPINHKFF vs ONHKFF vs KONHKFF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.